TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
TFF Pharmaceuticals Selects LaVoieHealthScience as Investor Relations and Corporate Communications Partner
November 19, 2019
November 18, 2019
October 24, 2019